HANXBIO-B (03378) has announced that, due to work adjustments, Ms. Xiao Jieyu has been reassigned from a Non-Executive Director to an Executive Director, effective from February 8, 2026.

Following Ms. Xiao's reassignment as an Executive Director, she will step down from her position as a member of the Audit Committee, also effective February 8, 2026.

Effective from February 8, 2026, Dr. Zhang Qiongguang, an Independent Non-Executive Director, has been appointed as a member of the Audit Committee.

The Board further announced that, due to personal career planning reasons, Mr. Zhang Hui has resigned from his positions as Joint Company Secretary, Deputy General Manager, Chief Financial Officer, and Board Secretary of the company, effective February 8, 2026.

Mr. Li Jianwei, the company's other Joint Company Secretary, will continue to serve as the Company Secretary.

The company has appointed Ms. Xiao as the primary contact person at its headquarters, responsible for maintaining daily communication with Mr. Li.

The Board further announced the appointment of Ms. Xiao to the roles of Chief Financial Officer and Board Secretary of the company, effective from February 8, 2026.

According to her service contract, Ms. Xiao will receive an annual basic salary of RMB 750,000 and a discretionary bonus, which will be determined by the Board from time to time with reference to, among other factors, her performance and the overall performance of the Group.